Financials
- Market Capitalization 7.1 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.15
Relación precio/flujo de caja
-909.61
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4887 | IMRN Immuron Limited - American Depositary Shares | 1.24 USD | +1.64% | -4.62% | +7.83% | -36.41% | 7.25 M USD | ||
| 4888 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 5.80 USD | +1.58% | -8.52% | -7.50% | -35.56% | 7.15 M USD | ||
| 4892 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.65 USD | +4.43% | +13.79% | +1.85% | -14.06% | 7.09 M USD | ||
| 4893 | ERNA Ernexa Therapeutics Inc. - Common Stock | 6.06 USD | +9.39% | -5.75% | +0.50% | +1633.91% | 7.07 M USD |